Browsing by Subject "C07K 14/005 (20130101)"
Now showing items 1-5 of 5
-
DNA Vaccine Expressing Ha1 of Equine-2 Influenza Virus
(U.S. Patent and Trademark Office, 2007-07-17)The invention is for a DNA vaccine expressing the hemagglutinin (HA1) gene of equine-2 influenza virus. By engineering a stop codon within HA1, expression of HA1 is ensured. By encapsulation of the DNA vaccine in liposome ... -
Engineered respiratory syncytial viruses with control of cell-to-cell virus transmission for enhanced safety of live virus vaccines
(U.S. Patent and Trademark Office, 2020-11-24)Highly antigenic yet safe vaccines against diseases caused by Paramyxoviridae viruses such as respiratory syncytial virus (RSV) are provided. The vaccines comprise attenuated Paramyxoviridae viruses with high antigenicity ... -
Vaccines Containing Canine Parvovirus Genetic Variants
(U.S. Patent and Trademark Office, 2012-07-24)Canine parvovirus vaccines and diagnostics and methods for their use are provided. -
Vaccines Containing Canine Parvovirus Genetic Variants
(U.S. Patent and Trademark Office, 2013-12-17)Canine parvovirus vaccines and diagnostics and methods for their use are provided. The vaccines are effective against emerging canine parvovirus variants. -
Vaccines Containing Canine Parvovirus Genetic Variants
(U.S. Patent and Trademark Office, 2012-09-04)Canine parvovirus vaccines and diagnostics and methods for their use are provided.